BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15258512)

  • 1. [Particular histological features of a case of Sweet's syndrome induced by G-CSF].
    Abecassis S; Ingen-Housz-Oro S; Cavelier-Balloy B; Arnulf B; Bachelez H; Dubertret L
    Ann Dermatol Venereol; 2004 Apr; 131(4):369-72. PubMed ID: 15258512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sweet's syndrome during therapy with granulocyte colony-stimulating factor in a patient with aplastic anaemia.
    Fukutoku M; Shimizu S; Ogawa Y; Takeshita S; Masaki Y; Arai T; Hirose Y; Sugai S; Konda S; Takiguchi T
    Br J Haematol; 1994 Mar; 86(3):645-8. PubMed ID: 7519039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte colony-stimulating factor-induced granulomatous dermatitis with enlarged histiocytes clinically manifesting as painful edematous nodules with high fever similar to Sweet's syndrome.
    Ozaki S; Funasaka Y; Takubo M; Matayoshi T; Ueno T; Asayama T; Saeki H
    J Dermatol; 2015 Apr; 42(4):414-7. PubMed ID: 25572429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propylthiouracil-induced anti-neutrophil cytoplasmic antibodies and agranulocytosis together with granulocyte colony-stimulating factor induced Sweet's syndrome in a patient with Graves' disease.
    Ozlem C; Deram B; Mustafa S; Koray T; Cuyan D; Ertugrul T
    Intern Med; 2011; 50(18):1973-6. PubMed ID: 21921379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sweet syndrome following therapeutic use of granulocyte colony stimulating factor].
    Veres K; Haraszti A; Nemes Z; Zeher M
    Orv Hetil; 1999 May; 140(19):1059-61. PubMed ID: 10339998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sweet's syndrome with subcutaneous involvement associated with pegfilgrastim treatment: first reported case.
    Llamas-Velasco M; García-Martín P; Sánchez-Pérez J; Fraga J; García-Diez A
    J Cutan Pathol; 2013 Jan; 40(1):46-9. PubMed ID: 23131080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet's syndrome.
    Walker DC; Cohen PR
    J Am Acad Dermatol; 1996 May; 34(5 Pt 2):918-23. PubMed ID: 8621829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sweet's syndrome induced by pegfilgrastim during a myelodysplastic syndrome AREB2: A case report].
    Nelis S; Azerad MA; Drowart A; Lewalle P; Efira A
    Rev Med Interne; 2019 Apr; 40(4):258-261. PubMed ID: 30551891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sweet's syndrome associated with acute myeloid leukemia. Report of one case].
    Molgó N M; de la Sotta F P; Giesen F L; González B S
    Rev Med Chil; 2011 Dec; 139(12):1592-6. PubMed ID: 22446706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sweet's syndrome associated with G-CSF.
    Paydaş S; Sahin B; Seyrek E; Soylu M; Gonlusen G; Acar A; Tuncer I
    Br J Haematol; 1993 Sep; 85(1):191-2. PubMed ID: 7504506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neutrophilic reaction of Sweet's syndrome type associated with the oral contraceptive.
    Tefany FJ; Georgouras K
    Australas J Dermatol; 1991; 32(1):55-9. PubMed ID: 1834046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bullous Sweet's syndrome in congenital neutropenia: association with pegfilgrastim.
    Draper BK; Robbins JB; Stricklin GP
    J Am Acad Dermatol; 2005 May; 52(5):901-5. PubMed ID: 15858487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sweet's syndrome associated with granulocyte colony-stimulating factor.
    Hasegawa M; Sato S; Nakada M; Nitta H; Shirasaki H; Kasahara K; Takehara K
    Eur J Dermatol; 1998; 8(7):503-5. PubMed ID: 9854164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bullous Sweet's syndrome after granulocyte colony-stimulating factor therapy in a child with congenital neutropenia.
    Akilov OE; Desai N; Jaffe R; Gehris RP
    Pediatr Dermatol; 2014; 31(2):e61-2. PubMed ID: 24387761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sweet's syndrome in a patient with chronic myeloproliferative disorder during recombinant human granulocyte colony stimulating factor therapy].
    Shiga Y; Shichishima T; Kamei K; Watanabe K; Ishibashi T; Maruyama Y
    Rinsho Ketsueki; 1995 Apr; 36(4):353-8. PubMed ID: 7540225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case of granulocyte colony-stimulating factor-induced Sweet's syndrome.
    Arbetter KR; Hubbard KW; Markovic SN; Gibson LE; Phyliky RL
    Am J Hematol; 1999 Jun; 61(2):126-9. PubMed ID: 10367792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sweet's syndrome in chronic lymphocytic leukemia associated with neutropenic fever and granulocyte colony stimulation factor.
    Thompson MA; Dyson SW; Faderl S
    Am J Hematol; 2006 Sep; 81(9):703-5. PubMed ID: 16838322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histiocytoid neutrophilic dermatoses and panniculitides: variations on a theme.
    Chow S; Pasternak S; Green P; Tremaine R; Reardon M; Murray S; Northgrave S; Walsh N
    Am J Dermatopathol; 2007 Aug; 29(4):334-41. PubMed ID: 17667165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bortezomib-induced Sweet's syndrome confirmed by rechallenge.
    Zobniw CM; Saad SA; Kostoff D; Barthel BG
    Pharmacotherapy; 2014; 34(4):e18-21. PubMed ID: 24338786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of herpes-like Sweet's syndrome in acute myelogenous leukemia during treatment with G-CSF.
    van Mook WN; Fickers MM; van der Kley JA; Theunissen PH
    Neth J Med; 1999 Nov; 55(5):235-41. PubMed ID: 10593134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.